Growing bodies of evidence have demonstrated that the identification of prostate cancer
(PCa) biomarkers in the patients' blood and urine may remarkably improve PCa diagnosis …

Research and clinical use of circulating cell-free DNA (cirDNA) is expanding rapidly;
however, there remain large gaps in our understanding of the influence of lifestyle and …

The analysis of biomarkers in biological fluids, also known as liquid biopsies, is seen with
great potential to diagnose complex diseases such as cancer with a high sensitivity and …

Abstract Analysis of cell‐free DNA methylation (cfDNAme), alone or combined with CA125,
could help to detect ovarian cancers earlier and may reduce mortality. We assessed …

Extracellular vesicles are shed by every cell type and can be found in any biofluid. They
contain different molecules that can be utilized as biomarkers, including several RNA …

The circulating cell-free nucleic acids (ccfNAs) consist of a heterogenous cocktail of both
single (ssNA) and double-stranded (dsNA) nucleic acids. These ccfNAs are secreted into the …

Introduction Natural antibody (NAb) derived from CD5+ B-1 cells maintains tissue
homeostasis, controls inflammation, aids in establishing long-term protective responses …

Objective Reasons for first trimester noninvasive prenatal screening (NIPS) test failure in
obese women remain elusive. As dilution from maternal sources may be explanatory, we …

Quantitative analysis of cell-free RNA (cfRNA) in plasma sample can be used for screening,
diagnosing, and prognosticating of multiple diseases. Here, we report a quantitative …

The advent of liquid biopsies presents a novel, minimally invasive methodology for the
detection of disease biomarkers, offering a significant advantage over traditional biopsy …